Chief Operating Officer of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL), Bunker Kevin D., sells 3,810 shares worth $171,450

According to Zentalis Pharmaceuticals, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Apr 14 05:06 PM, company Chief Operating Officer, Bunker Kevin D. disclosed selling 3,810 shares at a cost of $45.00. At the time of this transaction (Apr 13), this trade was worth $171,450 in total. As of Apr 13, Bunker Kevin D. now owns 50,520 shares in total worth about $2,374,945.1999999997.

For the last few recent trades made by Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Chief Operating Officer, Bunker Kevin D., we have the following information:

  1. SEC Form 4 filing: Apr 05: Sold 24,536 shares at the rate of $43.37 per share. Total worth of this trade was $1,064,107. Total number of shares owned as of Apr 05 were 1,019,928
  2. SEC Form 4 filing: Apr 05: Sold 400 shares at the rate of $45.07 per share. Total worth of this trade was $18,028. Total number of shares owned as of Apr 05 were 54,330
  3. SEC Form 4 filing: Apr 06: Sold 275 shares at the rate of $43.26 per share. Total worth of this trade was $11,897. Total number of shares owned as of Apr 06 were 1,019,653
Posted by on Wednesday April 14 2021, 7:37 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

Featured Press Releases

Log in